Chargement en cours...
In Vitro Dosing Performance of the ELLIPTA(®) Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)
Background: To evaluate the in vitro dose delivery characteristics of approved asthma and chronic obstructive pulmonary disease (COPD) therapies delivered via the ELLIPTA(®) dry powder inhaler across inhalation endpoints representative of the target patient population, using the Electronic Lung (eLu...
Enregistré dans:
| Publié dans: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Mary Ann Liebert, Inc.
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4685503/ https://ncbi.nlm.nih.gov/pubmed/26372465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2015.1225 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|